CIK 0001759138 · Non-accelerated filer<br>Smaller reporting company
Cabaletta Bio, Inc.
Sign in to watch- Ticker
- CABA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 759-3100
- Business address
- 2929 ARCH STREET, SUITE 600, PHILADELPHIA, PA, 19104
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-10-19 | Binder Gwendolyn See Remarks | Sale | −408 | $14.28 | $6K | 20,000 |
| 2023-10-19 | Binder Gwendolyn See Remarks | Option exercise · Stock Option (Right to Buy) | −11,000 | 133,756 | ||
| 2023-09-19 | Binder Gwendolyn See Remarks | Option exercise 10b5-1 | +11,000 | $1.01 | $11K | 31,000 |
| 2023-09-19 | Binder Gwendolyn See Remarks | Sale 10b5-1 | −10,300 | $17.50 | $180K | 20,700 |
| 2023-09-19 | Binder Gwendolyn See Remarks | Sale 10b5-1 | −700 | $18.50 | $13K | 20,000 |
| 2023-09-19 | Binder Gwendolyn See Remarks | Option exercise · Stock Option (Right to Buy) 10b5-1 | −11,000 | 144,756 | ||
| 2023-08-21 | Binder Gwendolyn See Remarks | Option exercise 10b5-1 | +11,000 | $1.01 | $11K | 31,000 |
| 2023-08-21 | Binder Gwendolyn See Remarks | Sale 10b5-1 | −10,700 | $13.41 | $143K | 20,300 |
| 2023-08-21 | Binder Gwendolyn See Remarks | Sale 10b5-1 | −300 | $13.82 | $4K | 20,000 |
| 2023-08-21 | Binder Gwendolyn See Remarks | Option exercise · Stock Option (Right to Buy) 10b5-1 | −11,000 | 155,756 | ||
| 2023-07-21 | Tomasello Shawn Director | Grant or award · Stock Option (Right to Buy) | +44,000 | 44,000 | ||
| 2023-07-19 | Binder Gwendolyn See Remarks | Option exercise 10b5-1 | +11,000 | $1.01 | $11K | 31,000 |
| 2023-07-19 | Binder Gwendolyn See Remarks | Sale 10b5-1 | −8,185 | $13.67 | $112K | 22,815 |
| 2023-07-19 | Binder Gwendolyn See Remarks | Sale 10b5-1 | −2,815 | $14.26 | $40K | 20,000 |
| 2023-07-19 | Binder Gwendolyn See Remarks | Option exercise · Stock Option (Right to Buy) 10b5-1 | −11,000 | 166,756 | ||
| 2023-06-20 | Binder Gwendolyn See Remarks | Option exercise 10b5-1 | +11,000 | $1.01 | $11K | 31,000 |
| 2023-06-20 | Binder Gwendolyn See Remarks | Sale 10b5-1 | −11,000 | $12.99 | $143K | 20,000 |
| 2023-06-20 | Binder Gwendolyn See Remarks | Option exercise · Stock Option (Right to Buy) 10b5-1 | −11,000 | 177,756 | ||
| 2023-06-01 | Simon Mark Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2023-06-01 | Bollard Catherine Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 |
Page 9 of 13 · 256 trades